Sabra Health Care REIT announced its third quarter 2020 results, with net income attributable to common stockholders at $0.18 per diluted common share, FFO at $0.41 per diluted common share, Normalized FFO at $0.48 per diluted common share, AFFO at $0.46 per diluted common share, and Normalized AFFO at $0.46 per diluted common share. The company is no longer normalizing COVID-19 related expenses and government grant income from FFO and AFFO.
Net income attributable to common stockholders, FFO, Normalized FFO, AFFO and Normalized AFFO per diluted common share were $0.18, $0.41, $0.48, $0.46 and $0.46, respectively.
EBITDARM Coverage for the Skilled Nursing/Transitional Care portfolio increased 0.18x over the second quarter of 2020 to 1.84x, and Skilled Mix remained stable at 39.0%.
Cash NOI margins for the Senior Housing - Managed portfolio increased 410 basis points over the second quarter of 2020 to 26.7% primarily due to recognizing $4.2 million of government grant income during the third quarter of 2020.
During the third quarter of 2020, the company issued 1.4 million shares of common stock under its at-the-market offering program for net proceeds of $21.1 million, maintaining a strong net debt to adjusted EBITDA of 4.91x (5.48x including the unconsolidated joint venture).
Sabra Health Care REIT's growth expectations continue to be impacted by the cost of capital. The company has seen improvements in the cost of debt while seeing continued volatility in the cost of equity. Sabra remains focused on maintaining a strong balance sheet with ample liquidity and a well-covered dividend, and continues to pursue opportunities for accretive growth, which it believes can primarily come from the skilled nursing, behavioral and addiction asset classes until the cost of equity stabilizes.
Visualization of income flow from segment revenue to net income